ACIU
#3396
AC Immune SA - Common Stock
2.4 2 USD
-0.01%
Market Price
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
Intervallo Annuale
Variazione giornaliera
-1.22%
Variazione Mensile
-11.36%
Variazione di 6 mesi
-26.89%
Variazione Annuale
-29.45%
Chiusura Precedente
2.4 5
Open
2.4 3
Minimo
2.3 9
Massimo
2.4 4
Financials
- Market Capitalization 246.22 M
- Employee 122
- Founded 2003
- CEO Andrea Pfeifer
- Website www.acimmune.com
- Headquarter Switzerland
- FIGI UNKNOWN
- Industry Biotecnologia
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 3385 |  BBOT BridgeBio Oncology Therapeutics, Inc. - Common Stock | 3.01 USD | -7.67% | -14.97% | -38.70% | -73.71% | 241.32 M USD | ||
| 3395 |  FATE Fate Therapeutics, Inc. - Common Stock | 2.01 USD | -5.63% | -14.10% | -12.61% | +45.65% | 240.84 M USD | ||
| 3410 |  LRMR Larimar Therapeutics, Inc. - Common Stock | 2.20 USD | -13.04% | -21.71% | -42.71% | -47.24% | 228.54 M USD | ||
| 3413 |  LCTX Lineage Cell Therapeutics, Inc. Common Stock | 0.90 USD | -5.26% | -4.26% | -11.76% | -47.58% | 227.62 M USD |